Retroperitoneal lymph-node dissection (RPLND) as upfront management in stage II germ-cell tumours: Evaluation of safety and efficacy

INTRODUCTION: Patients with stage II germ-cell tumours (GCT) usually undergo radiotherapy (seminoma only) or chemotherapy. Both strategies display a recognised risk of long-term side effects. We evaluated retroperitoneal lymph node dissection (RPLND) as exclusive treatment in stage II GCT. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicolai, Nicola, Nazzani, Sebastiano, Tesone, Antonio, Macchi, Alberto, Piva, Luigi, Salvioni, Roberto, Stagni, Silvia, Torelli, Tullio, Agostini, Edoardo, Celso, Francesco, Giannatempo, Patrizia, Procopio, Giuseppe, Avuzzi, Barbara, Lanocita, Rodolfo, Cattaneo, Laura, Catanzaro, Mario, Biasoni, Davide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363949/
https://www.ncbi.nlm.nih.gov/pubmed/35915559
http://dx.doi.org/10.1177/03008916221112697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363949/
https://www.ncbi.nlm.nih.gov/pubmed/35915559
http://dx.doi.org/10.1177/03008916221112697

Ejemplares similares